Me. Grace et al., Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 Gaucher disease, J CLIN INV, 103(6), 1999, pp. 817-823
Gaucher disease is an autosomal recessive inborn error of glycosphingolipid
metabolism caused by the deficient activity of the lysosomal hydrolase, ac
id beta-glucosidase. Three phenotypically distinct subtypes result from dif
ferent acid beta-glucosidase mutations encoding enzymes with absent or low
activity. A severe neonatal type 2 variant who presented with collodion ski
n, ichthyosis, and a rapid neurodegenerative course had two novel acid beta
-glucosidase alleles: a complex, maternally derived allele, E326K+L444P, an
d a paternally inherited nonsense mutation, E233X. Because the only other n
on-pseudogene-derived complex allele, D140H+E326K, also had the E326K lesio
n and was reported in a mild type 1 patient with a D140H+E326K/K157Q genoty
pe, these complex alleles and their individual mutations were expressed and
characterized. Because the E233X mutation expressed no activity and the K1
57Q allele had similar to 1% normal specific activity based on cross-reacti
ng immunologic material (CRIM SA) in the baculovirus system, the residual a
ctivity in both patients was primarily from their complex alleles. In the t
ype 1 patient, the D140H+E326K allele was neuroprotective, encoding an enzy
me with a catalytic efficiency similar to that of the N370S enzyme. In cont
rast, the E326K+L444P allele did not have sufficient activity to protect ag
ainst the neurologic manifestations and, in combination with the inactive E
233X lesion, resulted in the severe neonatal type 2 variant. Thus, characte
rization of these novel genotypes with non-pseudogene-derived complex mutat
ions provided the pathogenic basis for their diverse phenotypes.